Teva And Viatris Lean Into Innovative Medicines
Both companies – best known for selling generic drugs – are advancing new innovative medicines to the market.
Scrip - August 21, 2026

Finance Watch: Biopharma IPO Activity Booming In And Outside Of The US
Public Company Edition: Ingenia Therapeutics launched the 16th drug developer initial public offering outside of the US this year with a Kosdaq IPO. Also, Amylyx raised $500m in a post-data follow-on offering and Gossamer revealed a private placement for up to $250m.
Scrip - August 21, 2026

Ambros Raising $150m To Take Neridronate To Market Alone After Reverse Merger
Deal Snapshot: Ambros will go public through a reverse merger with Werewolf to develop the drug for CRPS-1. The company is building its commercial organization ahead of a 2028 Phase III readout.
Scrip - August 21, 2026

Two FDA Convenience Kit Alerts Linked To Huons Drug Components
Back-to-back safety alerts from the FDA involving medical kits containing drugs manufactured by Huons Co., highlight the agency's continuing concern over the South Korean company’s pharmaceutical products. The alerts affect surgical and epidural kits containing recalled drugs from the firm.
Medtech Insight - August 21, 2026

AI Could Transform Surgery. Bad Incentives May Keep It For The Wealthy Few.
J&J Medtech's new report argues that surgical AI's biggest obstacles are no longer technical — they are economic incentives, fragmented governance and a financing model that makes hospitals pay while payers capture the gains.
Medtech Insight - August 21, 2026

Three Reclassification Candidates Stall At Japan’s Latest Switch Committee Meeting
Three prescription medicines proposed for OTC sale in Japan for numbness in the elderly, all submitted under a single request, have stalled at the health ministry's switch evaluation committee.
HBW Insight - August 21, 2026

Silo Locks Down IP Rights For PTSD Asset As It Prepares 505(b)(2) Filing
?In a bid to shorten clinical timelines and reduce costs, Silo Pharma plans to use?the?Food and Drug Administration’s streamlined 505(b)(2) regulatory pathway to push forward with its PTSD treatment.? Meanwhile a Canadian patent has been granted following hot on the heels of a European patent.
Generics Bulletin - August 21, 2026

Richter Sees GenMed Recovery Stretching Into 2027
Richter expects its General Medicines business to return to mid-single-digit growth from 2027, with newer generics helping offset legacy-product erosion, distributor changes and market-specific setbacks that weighed on first-half performance.
Generics Bulletin - August 21, 2026

Executives On The Move: Ex-GSK Exec Joins OliX As It Expands Its RNAi Platform
Kailera gets a new CTO as it announces an upcoming oral Phase III program for its weight loss drug, ribupatide, and Bicara announces senior leadership transitions as it prepares for the potential commercialization of ficerafusp alfa in HNSCC.
Scrip - August 21, 2026

Bavarian Nordic Bucks Trend With Travel Vaccines Boost
France’s Valneva’s travel health products are suffering a fall in demand but that is not the case for its Denmark-headquartered competitor.
Scrip - August 21, 2026

Remembering Philip Brown, Founder Of Scrip
Dr Philip Brown, the UK journalist and entrepreneur behind specialist publishing company PJB Publications, established Scrip, launched further publications and products, and sold his publishing empire in 2003 for £150m. He died on August 2, 2026.
Scrip - August 21, 2026

Glenmark Builds On US Respiratory Portfolio With Generic Flonase Nasal Spray Approval
The latest FDA approval of a fluticasone propionate nasal spray further secures Glenmark’s ambition to resurrect its US presence with an expansive respiratory product portfolio.
Generics Bulletin - August 21, 2026

Sawai Launches Four First-Time Generics As Revenue Rises But Profit Falls In Q1
Sawai Pharmaceuticals records early revenue growth but falling operating profit in its first-quarter earnings report for a new fiscal year.
Generics Bulletin - August 21, 2026

CMS Grants NTAP For Aidoc’s Foundation-Model AI — A First For Broad Diagnostic Tools
CMS has granted Aidoc's CARE Body CT Multi-Triage an NTAP worth $137.53 per qualifying Medicare inpatient scan — the first such payment for a broad, multi-finding, foundation-model AI, covering many conditions at once rather than one disease at a time.
Medtech Insight - August 21, 2026

CSPC Advances Chemo-Free ADC Combo In 1L NSCLC
Chinese firm will present at WCLC Phase II results supporting a combination of SYS6010, an anti-EGFR ADC, plus anti-PD-1 drug enlonstobart for first-line, PD-L1-positive NSCLC.
Scrip - August 21, 2026

Bonus Podcast: EndoCyclic’s Peptide Strategy For Endometriosis Diagnosis And Treatment
One in ten women has endometriosis, yet treatment options remain largely unchanged for decades. In this bonus podcast episode, Tanya Petrossian, CEO of EndoCyclic Therapeutics, explains how her company's non-hormonal peptide platform, now FDA-cleared for human trials, could finally change that.
In Vivo - August 21, 2026

China Presents Stella Opportunities For BNCT
The freer regulatory environment in China's Hainan opens an important expansion path for Japanese boron therapy specialist.
Scrip - August 21, 2026

EU PPWR: Minimizing Medtech Packaging Without Losing Protection
Starting in 2030, the PPWR prohibits unnecessary empty spaces and decorative fillers. In medtech, where size affects sterility, stability, and handling, every void must have a purpose, not just aim for zero empty space. Experts advise that proper documentation is key, and the time to begin is now.
Medtech Insight - August 21, 2026

US Consumer Health People Moves: Kimberly-Clark, Dude Wipes, InstaMed, Coffee+, Juice Plus+
Kimberly-Clark promotes Suzana Blades to general counsel; Dude Wipes brand expands executive suite for first time since its founding with a chief product officer; and CEO changes at Juice Plus+, InstaMed and Everyday Dose.
HBW Insight - August 21, 2026